NYSE:ELN - Elan Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
Previous CloseN/A
Today's RangeN/A
52-Week RangeN/A
VolumeN/A
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Elan Corporation Ltd (Elan), formerly Elan Corporation, plc, is a biotechnology company. The Company is focused on discovering and developing advanced therapies in neurodegenerative and autoimmune diseases. On February 6, 2013, the Company announced that it has entered into an asset purchase agreement with Biogen Idec to transfer to Biogen Idec all Tysabri IP and other assets related to Tysabri. As of 31 December 2012, there were approximately 72,700

Receive ELN News and Ratings via Email

Sign-up to receive the latest news and ratings for ELN and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NYSE
Industry N/A
Sub-IndustryN/A
SectorN/A
Current SymbolNYSE:ELN
Previous Symbol
CUSIPN/A
Phone+353-1-7094000

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

EmployeesN/A
Outstanding SharesN/A
Market Cap$0.00
OptionableNot Optionable

Elan (NYSE:ELN) Frequently Asked Questions

What is Elan's stock symbol?

Elan trades on the New York Stock Exchange (NYSE) under the ticker symbol "ELN."

Has Elan been receiving favorable news coverage?

News headlines about ELN stock have trended neutral this week, according to InfoTrie Sentiment. The research group identifies positive and negative news coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. Elan earned a media sentiment score of 0.4 on InfoTrie's scale. They also assigned press coverage about the biotechnology company a news buzz of 10.0 out of 10, indicating that recent news coverage is extremely likely to have an impact on the company's share price in the next several days.

How do I buy shares of Elan?

Shares of ELN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Elan's official website?

The official website for Elan is http://www.elan.com.

How can I contact Elan?

Elan's mailing address is Treasury Building Grand Canal Street Lower, DUBLIN, 2, Ireland. The biotechnology company can be reached via phone at +353-1-7094000.


MarketBeat Community Rating for Elan (NYSE ELN)

Community Ranking:  2.2 out of 5 (star star)
Outperform Votes:  82 (Vote Outperform)
Underperform Votes:  101 (Vote Underperform)
Total Votes:  183
MarketBeat's community ratings are surveys of what our community members think about Elan and other stocks. Vote "Outperform" if you believe ELN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ELN will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 11/20/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel